Westchester Capital Management (New York)’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Westchester Capital Management (New York)’s Portfolio DALS Stock Details DALS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$2.88M	Hold
2023 Q1	$2.84M	Hold
2022 Q4	$2.78M	Buy
2022 Q3	$1.61M	Hold
2022 Q2	$1.61M	Hold
2022 Q1	$1.62M	Buy